64 results on '"De Deyn, Peter P"'
Search Results
2. The neglected puzzle of dementia in people with severe/profound intellectual disabilities: A systematic literature review of observable symptoms
3. Dementia in people with severe or profound intellectual (and multiple) disabilities: Focus group research into relevance, symptoms and training needs
4. Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
5. Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis
6. Dynamics of neutrophil gelatinase‐associated lipocalin plasma and cerebrospinal fluid concentrations in older males
7. Impaired hypoxic tolerance in APP23 mice: a dysregulation of neuroprotective globin levels
8. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
9. Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
10. Quantitative STIR of muscle for monitoring nerve regeneration
11. Could ecosystem management provide a new framework for Alzheimer's disease?
12. P4-194: The identification of high-penetrant loss-of-function mutations in abca7 in Alzheimer's disease
13. DT-02-01: Loss-of-function mutations in TBK1 are frequently associated with frontotemporal lobar degeneration in a belgian patient cohort
14. O4-11-03: Limited impact of CSF biomarkers variability on clinical diagnosis in autopsy-confirmed Alzheimer's disease
15. P3-017: Rare variants in PLD3 do not increase risk in a belgian cohort of early-onset Alzheimer dementia patients
16. O1-09-05: VALIDATION OF THE AD-CSF INDEX IN AUTOPSY CONFIRMED AD PATIENTS AND HEALTHY CONTROLS
17. P1-053: OLFACTORY RECEPTOR COPY NUMBER VARIATION INVOLVED IN ALZHEIMER'S DISEASE
18. Intracranial pressure fluctuations: a potential risk factor for glaucoma?
19. Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis
20. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease
21. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia
22. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome
23. Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults
24. Lipocalin 2: Novel component of proinflammatory signaling in Alzheimer's disease
25. Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice
26. O4-03-07: Association of intermediate-length polyQ expansions in ATXN2 with ALS but not FTLD in a flanders-belgian cohort
27. P3-231: Plasma beta-amyloid levels: Diagnostic markers for dementia diagnosis?
28. O1-03-08: TMEM106B the first common risk factor for FTLD: Replication in a clinically diagnosed cohort of FTLD patients
29. O1‐03‐01: In‐depth molecular genetic analysis of CLU in Alzheimer's disease
30. P3‐262: Longitudinal stability of CSF biomarker levels
31. P3-241: Standardization of CSF sampling to minimize variation in CSF biomarker levels
32. O4-06-08: A multigenerational family with inherited, pathologically confirmed Creutzfeldt-Jakob disease unexplained by PRNP
33. Serum biomarker for progranulin‐associated frontotemporal lobar degeneration
34. P3-080: Value of CSF biomarkers in differential dementia diagnosis
35. P1-349: Plasma amyloid isoforms allow screening for mild cognitive impairment among healthy elderly
36. O3-06-05: Progression of frontal lobe symptoms in frontotemporal dementia and dementia with Lewy bodies as compared with Alzheimer's disease
37. P3-068: Improved discrimination of Alzheimer's disease from other dementias using cerebrospinal fluid P-tau181P
38. P3‐392: The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia
39. P1‐344: Plasma amyloid isoforms in non‐Alzheimer's disease patients
40. O2-07-02: Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment?
41. P1‐166: CSF biomarkers predict conversion to dementia in mild cognitive impairment
42. P3‐266: GAB2 and risk for Alzheimer's dementia in a Belgian population
43. Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
44. Development of dyskinesias in a 5-year trial of ropinirole and L -dopa
45. P1–074: Eating & drinking in an APP hyperexpression model
46. P3-158: A novel locus for autosomal dominant dementia with Lewy bodies on chromosome 2Q35-36
47. O3–01–06: Diagnostic performance of a CSF–biomarker panel compared to clinical diagnosis in 100 autopsy–confirmed dementia cases
48. P4-176: Actigraphic measurement of agitated behavior in Dementia
49. P1-425: Behavioral and neuropsychological correlates of frontal lobe features in dementia
50. P3-149: An ancestral haplotype harbors a highly prevalent mutation for 17q21-linked tau-negative FTLD in Belgium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.